JP2001512451A5 - - Google Patents

Download PDF

Info

Publication number
JP2001512451A5
JP2001512451A5 JP1998535351A JP53535198A JP2001512451A5 JP 2001512451 A5 JP2001512451 A5 JP 2001512451A5 JP 1998535351 A JP1998535351 A JP 1998535351A JP 53535198 A JP53535198 A JP 53535198A JP 2001512451 A5 JP2001512451 A5 JP 2001512451A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1998535351A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001512451A (ja
Filing date
Publication date
Priority claimed from GBGB9703099.3A external-priority patent/GB9703099D0/en
Priority claimed from GBGB9703101.7A external-priority patent/GB9703101D0/en
Priority claimed from GBGB9703100.9A external-priority patent/GB9703100D0/en
Application filed filed Critical
Priority claimed from PCT/EP1998/000811 external-priority patent/WO1998035672A1/en
Publication of JP2001512451A publication Critical patent/JP2001512451A/ja
Publication of JP2001512451A5 publication Critical patent/JP2001512451A5/ja
Ceased legal-status Critical Current

Links

JP53535198A 1997-02-14 1998-02-10 アモキシシリンおよびクラブラン酸塩を含む医薬処方 Ceased JP2001512451A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GBGB9703099.3A GB9703099D0 (en) 1997-02-14 1997-02-14 Formulations
GB9703101.7 1997-02-14
GB9703100.9 1997-02-14
GBGB9703101.7A GB9703101D0 (en) 1997-02-14 1997-02-14 Formulations
GB9703099.3 1997-02-14
GBGB9703100.9A GB9703100D0 (en) 1997-02-14 1997-02-14 Formulations
PCT/EP1998/000811 WO1998035672A1 (en) 1997-02-14 1998-02-10 Pharmaceutical formulations comprising amoxocyllin and clavulanate

Publications (2)

Publication Number Publication Date
JP2001512451A JP2001512451A (ja) 2001-08-21
JP2001512451A5 true JP2001512451A5 (enExample) 2005-10-06

Family

ID=27268719

Family Applications (1)

Application Number Title Priority Date Filing Date
JP53535198A Ceased JP2001512451A (ja) 1997-02-14 1998-02-10 アモキシシリンおよびクラブラン酸塩を含む医薬処方

Country Status (25)

Country Link
EP (2) EP1142574A1 (enExample)
JP (1) JP2001512451A (enExample)
KR (1) KR100499812B1 (enExample)
CN (1) CN1194687C (enExample)
AP (1) AP1253A (enExample)
AT (1) ATE243516T1 (enExample)
AU (1) AU728526B2 (enExample)
BG (1) BG103664A (enExample)
BR (1) BR9807383A (enExample)
CA (1) CA2280857A1 (enExample)
DE (1) DE69815833T2 (enExample)
DZ (1) DZ2420A1 (enExample)
EA (1) EA002595B1 (enExample)
ES (1) ES2201468T3 (enExample)
HK (1) HK1043041A1 (enExample)
ID (1) ID23673A (enExample)
IL (1) IL131201A (enExample)
MA (1) MA24473A1 (enExample)
NO (1) NO993887D0 (enExample)
NZ (1) NZ337043A (enExample)
OA (1) OA11087A (enExample)
PL (1) PL334976A1 (enExample)
SK (1) SK110299A3 (enExample)
TR (1) TR199901961T2 (enExample)
WO (1) WO1998035672A1 (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9416600D0 (en) * 1994-08-17 1994-10-12 Smithkline Beecham Plc Pharmaceutical formulation
DK0862431T3 (da) 1995-09-07 2002-03-11 Smithkline Beecham Plc Anvendelse af pædiatrisk farmaceutisk formulering omfattende amoxycillin og clavulanat
GB9815532D0 (en) * 1998-07-17 1998-09-16 Lek Pharmaceutical & Cvhemical Pharmaceutical suspension formulation
WO2000050036A1 (en) * 1999-02-26 2000-08-31 Biovail International Ltd. Storage stable amoxycillin and clavulanate suspension composition
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
IL145580A0 (en) * 1999-04-13 2002-11-10 Beecham Pharm Pte Ltd A modified release pharmaceutical composition comprising amoxycillin and potassium clavulanate
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
FR2797588B1 (fr) * 1999-08-20 2003-08-01 Smithkline Beecham Lab Formulation pharmaceutique a base d'amoxycilline et de clavulanate
AU6571400A (en) * 1999-08-20 2001-03-19 Smithkline Beecham Laboratoires Pharmaceutiques S.A.S. Pharmaceutical formulation comprising amoxycillin and clavulanate
US6541025B1 (en) * 1999-12-30 2003-04-01 Shear/Kershman Laboratories, Inc. Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals
US6375982B1 (en) * 2000-07-05 2002-04-23 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and method of using same
AU2001292185A1 (en) 2000-10-12 2002-04-22 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
AT412344B (de) * 2001-04-12 2005-01-25 Sandoz Ag Hydrophobisierte teilchen von k-clavulanat
AT413983B (de) * 2001-04-12 2006-08-15 Sandoz Ag K-clavulanat in der form eines granulates
WO2003063820A2 (en) * 2002-02-01 2003-08-07 Sandoz Gmbh Demixing-stable granulate
ES2314227T7 (es) * 2002-04-09 2012-11-19 Flamel Technologies Formulacion farmaceutica oral en forma de suspension acuosa de microcapsulas que permiten la liberacion modificada de amoxilicina.
CN1681497A (zh) * 2002-07-16 2005-10-12 兰贝克赛实验室有限公司 口服给药用的可分散片剂
KR20060010838A (ko) * 2003-06-16 2006-02-02 글락소 그룹 리미티드 아목시실린 및 클라블라네이트를 포함하는 약제학적 제형
KR100676617B1 (ko) * 2004-06-18 2007-01-30 주식회사유한양행 아목시실린 및/또는 클라불란산 또는 이의 염을 함유하는경구용 현탁정제 조성물
SI21912A (sl) * 2004-12-24 2006-06-30 Lek Farmacevtska Druzba D.D. Stabilne farmacevtske oblike, ki vsebujejo amoksicilin in klavulansko kislino
DE102006007830A1 (de) * 2006-02-17 2007-08-30 Grünenthal GmbH Lagerstabile orale Darreichungsform von Amoxicillin und Clavulansäure
CN100464750C (zh) * 2006-02-23 2009-03-04 珠海联邦制药股份有限公司 一种制备含阿莫西林钠和克拉维酸钾的药物混合物的方法
US8951562B2 (en) 2006-11-10 2015-02-10 Atacama Labs Oy Method and apparatus or dry granulation
FI20080352A0 (fi) * 2008-05-09 2008-05-09 Atacama Labs Oy Prosessi korkean lääkepitoisuuden tabletin valmistamiseksi
FI20080351A0 (fi) * 2008-05-09 2008-05-09 Atacama Labs Oy Prosessi matalan lääkepitoisuuden tabletin valmistamiseksi
FI20070521A7 (fi) 2006-11-10 2008-05-11 Atacama Labs Oy Rakeita, tabletteja ja rakeistusmenetelmä
WO2009135946A1 (en) 2008-05-09 2009-11-12 Atacama Labs Oy Method and apparatus for dry granulation
CN102861015B (zh) * 2011-07-05 2015-07-08 北京乐维生物技术有限公司 一种稳定的阿莫西林克拉维酸钾缓释制剂及其制备工艺
WO2014065769A1 (en) * 2012-10-22 2014-05-01 Bilgiç Mahmut Formulations for oral suspensions comprising antibiotics
ES2780874T3 (es) * 2013-09-20 2020-08-27 Centrient Pharmaceuticals Netherlands B V Comprimido que comprende crospovidona
US9254261B2 (en) * 2014-03-03 2016-02-09 Sandoz Ag Stable quick dissolving dosage form comprising amoxicillin and clavulanic acid
KR102002906B1 (ko) * 2016-10-18 2019-07-23 경동제약 주식회사 셀레콕시브를 포함하는 정제
EP3994154A1 (en) 2019-07-05 2022-05-11 GlaxoSmithKline Intellectual Property (No.2) Limited Streptomyces clavuligerus
CN113274357B (zh) * 2021-05-28 2022-12-27 广州白云山医药集团股份有限公司白云山制药总厂 一种阿莫西林药物及其制备方法
CN114869884A (zh) * 2021-07-30 2022-08-09 江苏恒丰强生物技术有限公司 一种用于猪呼吸道疾病的复方阿莫西林粉及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110165A (en) * 1974-04-20 1978-08-29 Beecham Group Limited Process for the production of clavulanic acid
US4140764A (en) * 1974-12-18 1979-02-20 Beecham Group Limited β-Lactamase inhibitors and process for their preparation
JO984B1 (en) * 1977-10-11 1979-12-01 بيتشام غروب ليمتد A dry pharmaceutical compound with a suitable dosage unit for oral administration
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
EP1034784A3 (en) * 1993-01-22 2001-06-27 Smithkline Beecham Plc Pharmaceutical formulations containing clavulanic acid and an antibacterial agent
IL109770A0 (en) * 1993-05-29 1994-11-28 Smithkline Beecham Corp Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby
GB9402203D0 (en) * 1994-02-04 1994-03-30 Smithkline Beecham Plc Pharmaceutical formulation
GB9405856D0 (en) * 1994-03-24 1994-05-11 Smithkline Beecham Plc Pharmaceutical formulation
GB9407386D0 (en) * 1994-04-14 1994-06-08 Smithkline Beecham Plc Pharmaceutical formulation
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
DZ1926A1 (fr) * 1994-09-03 2002-02-17 Smithkline Beckman P L C Formulations pharmaceutiques.

Similar Documents

Publication Publication Date Title
JP2000510751A5 (enExample)
JP2000509942A5 (enExample)
JP2000509912A5 (enExample)
JP2000509635A5 (enExample)
JP2000507042A5 (enExample)
JP2000509637A5 (enExample)
JP2002514959A5 (enExample)
JP2000509587A5 (enExample)
JP2000507369A5 (enExample)
JP2000507433A5 (enExample)
JP2001517399A5 (enExample)
JP2000510793A5 (enExample)
JP2001508265A5 (enExample)
JP2000508022A5 (enExample)
JP2000508841A5 (enExample)
JP2000508680A5 (enExample)
JP2002506442A5 (enExample)
JP2000509804A5 (enExample)
JP2001518164A5 (enExample)
JP2000509755A5 (enExample)
JP2000510969A5 (enExample)
JP2000510247A5 (enExample)
JP2000508102A5 (enExample)
JP2000509818A5 (enExample)
JP2000507434A5 (enExample)